Forschungsstelle für Pharmarecht hat dies direkt geteilt
📢 Dr. Christian Stallberg at the 28th Marburger Gespräche 📢 📅 The healthcare sector is facing dynamic regulatory challenges – from supply shortages to new pricing structures. On March 13–14, 2025, leading experts will gather at the 28th Marburger Gespräche on Pharmaceutical Law to discuss key topics surrounding advertising & marketing, the complexities of pricing and reimbursement law, and the evolving challenges of digitalization in pharmaceutical companies. The Marburger Gespräche have become an essential platform for thought-provoking discussions on pharmaceutical law. Each year, experts from law firms, the pharmaceutical industry, and academia come together to examine pressing legal challenges from different angles. 📈As in previous years, the agenda is shaped through open exchanges with leading industry stakeholders. At #NOVACOS, we are honored to have played an active role in shaping these discussions for many years. Once again, one of our partners – Dr. Christian Stallberg – will contribute with a lecture, continuing our commitment to advancing the dialogue on pharmaceutical law. 🧠Christian will share insights on the topic: "Legal Issues of the Combination Discount for AMNOG Pharmaceuticals" Pricing regulations for innovative medicines are becoming increasingly complex, especially with the new combination discount rules that came into force in October last year. But what does this mean for pharmaceutical companies in practice? Christian will explore practical solutions and provide valuable insights into current legal disputes. 🤝 We look forward to engaging discussions with colleagues and industry experts! Forschungsstelle für Pharmarecht Philipps-Universität Marburg #PharmaceuticalLaw #AMNOG #HealthcareLaw #PharmaIndustry #NOVACOSontour #NOVACOS